See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Zacks Research Has Pessimistic View of Chemours Q2 Earnings

Summary by defenseworld.net
The Chemours Company (NYSE:CC – Free Report) – Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Chemours in a report released on Wednesday, July 9th. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will earn $0.40 per share for the quarter, down from their previous estimate of $0.47. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks R…

1 Articles

defenseworld.netdefenseworld.net
Center

Zacks Research Has Pessimistic View of Chemours Q2 Earnings

The Chemours Company (NYSE:CC – Free Report) – Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Chemours in a report released on Wednesday, July 9th. Zacks Research analyst R. Department now anticipates that the specialty chemicals company will earn $0.40 per share for the quarter, down from their previous estimate of $0.47. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks R…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Friday, July 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wilmington, Delaware icon

Wilmington, Delaware

News
For You
SearchBlindspotLocal